Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Ahlehoff

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Circulation. Cardiovascular Quality and Outcomes|October 16, 2014
Prognosis after first-time myocardial infarction in patients with inflammatory bowel disease according to disease activity: nationwide cohort studySøren Lund Kristensen, Ole Ahlehoff, Jesper Lindhardsen, et al.
Cardiovascular Diabetology|September 17, 2010
Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort studyCasper H Jørgensen, Gunnar H Gislason, Charlotte Andersson, et al.
Plos One|May 5, 2012
Pharmacological undertreatment of coronary risk factors in patients with psoriasis: observational study of the Danish nationwide registriesOle Ahlehoff, Lone Skov, Gunnar Gislason, et al.
Journal of the American College of Cardiology|January 22, 2011
Calcium-channel blockers do not alter the clinical efficacy of clopidogrel after myocardial infarction: a nationwide cohort studyJonas B Olesen, Gunnar H Gislason, Mette G Charlot, et al.
European Heart Journal|August 16, 2011
Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort StudyOle Ahlehoff, Gunnar H Gislason, Casper H Jørgensen, et al.
Plos One|April 6, 2011
Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort studyOle Ahlehoff, Gunnar Hilmar Gislason, Jesper Lindhardsen, et al.
BMJ (Clinical Research Ed.)|May 13, 2011
Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched studyMette Charlot, Erik L Grove, Peter Riis Hansen, et al.
Annals of Internal Medicine|September 22, 2010
Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort studyMette Charlot, Ole Ahlehoff, Mette Lykke Norgaard, et al.
European Heart Journal|July 17, 2012
Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort studyMette Charlot, Lars Hougaard Nielsen, Jesper Lindhardsen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 13, 2025
Prognosis of Calcified Lesions Treated With PCI in Patients With Chronic Coronary Artery DiseaseJulie Juul Siig, Marc Meller Søndergaard, Laust Dupont Rasmussen, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Circulation. Cardiovascular Quality and Outcomes|October 16, 2014
Prognosis after first-time myocardial infarction in patients with inflammatory bowel disease according to disease activity: nationwide cohort studySøren Lund Kristensen, Ole Ahlehoff, Jesper Lindhardsen, et al.
Cardiovascular Diabetology|September 17, 2010
Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort studyCasper H Jørgensen, Gunnar H Gislason, Charlotte Andersson, et al.
Plos One|May 5, 2012
Pharmacological undertreatment of coronary risk factors in patients with psoriasis: observational study of the Danish nationwide registriesOle Ahlehoff, Lone Skov, Gunnar Gislason, et al.
Journal of the American College of Cardiology|January 22, 2011
Calcium-channel blockers do not alter the clinical efficacy of clopidogrel after myocardial infarction: a nationwide cohort studyJonas B Olesen, Gunnar H Gislason, Mette G Charlot, et al.
European Heart Journal|August 16, 2011
Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort StudyOle Ahlehoff, Gunnar H Gislason, Casper H Jørgensen, et al.
Plos One|April 6, 2011
Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort studyOle Ahlehoff, Gunnar Hilmar Gislason, Jesper Lindhardsen, et al.
BMJ (Clinical Research Ed.)|May 13, 2011
Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched studyMette Charlot, Erik L Grove, Peter Riis Hansen, et al.
Annals of Internal Medicine|September 22, 2010
Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort studyMette Charlot, Ole Ahlehoff, Mette Lykke Norgaard, et al.
European Heart Journal|July 17, 2012
Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort studyMette Charlot, Lars Hougaard Nielsen, Jesper Lindhardsen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 13, 2025
Prognosis of Calcified Lesions Treated With PCI in Patients With Chronic Coronary Artery DiseaseJulie Juul Siig, Marc Meller Søndergaard, Laust Dupont Rasmussen, et al.
Pageof 7